Microbiology: a dangerous profession? by Mercè Piqueras
PERSPECTIVES
The history of science contains many cases of researchers
who have died because of their professional activity. In the
field of microbiology, some have died or have come close to
death from infection by agents that were the subject of their
research (Table 1). Infections that had a lethal outcome were
usually accidental. Sometimes, however, researchers inocu-
lated themselves with the pathogen or did not take preventive
measures against the potential pathogen because they wanted
to prove their hypotheses—or disprove someone else’s—
regarding the origin of the infection. Here is an overview of
several episodes in the history of microbiology since the mid
nineteenth century involving researchers or workers in fields
related to microbiology who have become infected. They are
considered here in their historical context to provide insights
into some of the pillars of modern microbiology—the giants
on whose shoulders several generations of microbiologists
have stood to see further.
From the Lady with the Lamp to the Lady with
the Microscope. Mediterranean, Malta, Gibraltar, and
Crimean fever are several of the names by which the disease
called undulant fever after 1913—now brucellosis—was tra-
ditionally known. It was predominant in the Mediterranean
region and its history has been associated to military medi-
cine. Hoover and Friedlander refer to British army surgeon
George Cleghorn (1716-1789), who was sent to Minorca dur-
ing the British domination of the Balearic island, and
described cases of chronic, relapsing febrile illness [16].
Cleghorn, who was in Minorca from 1736 to 1749, practiced
medicine not only among British soldiers but also among the
locals, and gathered a wealth of data about the most frequent
diseases in the island. The result of his observations was a
311-page book titled Observations on the epidemical dis-
eases in Minorca from the year 1744 to 1749 to which is pre-
fixed, a short account of the climate, productions, inhabi-
tants, and endemical distempers of that island (T. Cadell, D.
Wilson and G. Nicol, London, 1751), which he dedicated to
the Society of Surgeons of His Majesty’s Royal Navy.
Minorcan historian of science Josep M. Vidal Hernández has
described and carefully analyzed Cleghorn’s work in
Minorca and his report [43]. According to Vidal, what
Cleghorn describes is “tertian” fever, which was the name
given at the time to fever caused by malaria parasites with a
periodicity of 48 hours. In fact, Cleghorn used quinine to
treat tertian fever (i.e, malaria), which was not eradicated
from Minorca until the 1940s [43,44]. It was Spanish army
surgeon Manuel Rodríguez y Caramazana (1765-1836),
appointed Cirujano Mayor (Chief Surgeon) of the Militar
Hospital of Minorca in 1802, who clearly referred to Malta
fever in Minorca in 1813. He published an eight-page pam-
phlet titled Modo de precaver a Menorca de la peste de
Malta (How to protect Minorca from the plague of Malta).
The pamphlet was not received warmly because of the strict
preventive measures he proposed [45].
The British army surgeon Jeffrey Allen Marston (1831-
1911) contracted Malta fever in 1861 and described his own
case in great detail in the statistical report of the British Army
Medical Department that Marston wrote that same year, but
published in 1863. Marston first distinguished Malta fever
from other Mediterranean fevers [16,19], even though he did
not know what the causal agent of the disease was. Another
British army physician and microbiologist, Surgeon Captain
David Bruce (1855-1931), with his wife and close collabora-
tor Mary, succeeded in culturing the causal agent from the
spleen of a patient who had died from Malta fever. Bruce
named it Micrococcus melitensis, now known as Brucella
melitensis [42]. The discoveries that apparently healthy goats
could be the reservoir for the bacterium, and that milk of nat-
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urally infected goats was the source of human infection were
made in 1905 by Themistocles Zammit (1864-1935), a
Maltese physician whose role in the history of brucellosis has
not always been credited. Zammit carried out experiments
and epidemiological studies to prove his hypothesis, and
found bacteria in the milk, blood and urine of infected goats.
He even devised tests that were later used by others [47].
A few years before Marston’s illness, Florence
Nightingale (1820-1910), the British founder of modern
nursing who made major contributions to public health and
epidemiology during the Crimean War, had fallen ill with
what was then called Crimean fever. After reading an account
of the conditions of the British Army at Scutari (the district
of Istanbul now known as Üsküdar), Nightingale had volun-
teered to go to Crimea leading a team of 38 nurses. British
soldiers who had been wounded in the battlefront in the
Crimean Peninsula, and diagnosed with medical diseases (in
the mid-nineteenth century the cause of infectious diseases
was still to be discovered) in the hospitals of Balaclava on the
north shore of the Black Sea, were transported to Scutari to
isolate them from healthy troops. Many soldiers succumbed
during the journey across the Black Sea, which took around
thirteen days [13]. Those who reached Scutari alive were
more likely to die from infections in the hospital than as a
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Table 1. Some microbiologists or people who worked in fields related to microbiology who contracted the disease in which
they worked (see text for details of each case)
Disease Causal agent Researcher or worker infected Year
Brucellosis Brucella melitensis Florence Nightingales 1855
Brucella melitensis Jeffrey A. Marstons 1861
Brucella melitensis Alice C. Evanss 1922
Carrion’s disease Bartonella bacilliformis Daniel Alcides Carriónd 1885
Bartonella bacilliformis Ovidio García Rosells 1928
Bartonella bacilliformis Maxime Kuczynski-Godards 1937
Cholera Vibrio cholera Louis Thuillierd 1883
Vibrio cholera Max von Pettenkofers 1892
Epidemic typhus Rickettsia prowazekii Howard Taylor Rickettsd 1910
Rickettsia prowazekii Stanislaus von Prowazekd 1915
Rocky Mountain spotted fever Rickettsia ricketsii Thomas Bailey McClinticd 1912
Rickettsia ricketsii Henry Cowand,f 1924
Yellow fever Yellow fever virus Elihu H. Smithd 1798
Yellow fever virus Jesse W. Lazeard 1900
Yellow fever virus James Carrolls 1900
Yellow fever virus Adrian Stokesd 1927
Yellow fever virus Hideyo Noguchid 1928
Yellow fever virus William A. Youngd 1928
Eastern equine encephalitis EEE virus Richard E. Shopes 1959
Lassa fever Lassa fever virus Jordi Casals-Ariets 1969
Lassa fever virus Juan Romand,t 1969
Gastric ulcer Helicobacter pylori Barry Marshalls 1982
Sever acute respiratory syndrome SARS virus Carlo Urbanid 2003
sSurvived the disease. dDied from the disease. fField worker. tTechnician.
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result of the war (for every soldier who died from his
wounds, seven died from diseases contracted during their
hospital stay).
Although Nightingale did not know about the role of bac-
teria and viruses in infection, she clearly understood the con-
cept of contagion, the transmission of disease from person to
person. Her accurate records and statistics proved the rela-
tionship between filthy conditions and mortality. The work
she and her team of nurses carried out in Scutari resulted in a
dramatic reduction in mortality among hospitalized soldiers
[26]. The death rate among patients, which in February 1855
was 42.7%, decreased to 2.2% in June 1855 after the reforms
in hygiene Nightingale introduced. Many current health-care
practices, including cleansing of patient areas, aseptic prepa-
ration of foods, ventilation of wards, disposal of human and
medical wastes, isolation of patients with antibiotic-resistant
pathogens, and measures to prevent cross-contamination, are
based on the work Nightingale undertook in Scutari [29]. At
night, when orderlies substitued for the nurses, she was the
only nurse in the wards. To check on the wounded soldiers
she carried a lamp to see them in the dark, so patients called
her “the lady with lamp.”
On May 2 1855, while Nightingale was in Balaclava to
inspect the hospitals there, she fell ill. Her severe symptoms
and high fever forced her to stay in bed. The following weeks
her condition was typical of undulant fever: she felt better in
the morning and very ill again in the evening. By May 24,
doctors considered that although she was still very weak, she
was out of danger. Even though Nightingale died at the age
of 90, after the Crimean war she became an invalid and was
bedridden for many years before her death. Physicians of her
time tended to consider her a malingerer or maintained that
she was suffering from neurasthenia. Among twentieth-cen-
tury authors who have studied her life, several have assumed
that no organic disease could account for her illness. Others,
however, have considered the symptoms she suffered after
her return to Britain consistent with chronic brucellosis,
especially brucellosis caused by Brucella melitensis. 
Evidence for the existence of chronic brucellosis was
obtained during the first half of the twentieth century, when
Alice Catherine Evans (1881-1975), a microbiologist who
studied the bacteria in fresh milk, became infected herself
with Brucella. In 1918, Evans established the close relation
between the causal agent of undulant fever in humans—
Brucella melitensis—and that of abortion fever in cows—
Brucella abortus. She found them indistinguishable in mor-
phology and in culture requirements, and found that when
inoculated into pregnant guinea pigs, the proportion of abor-
tions was the same in both species. (Currently Brucella is
considered to be a monospecific genus that should be named
B. melitensis, and all other species are subtypes, with an
interspecies homology greater than 87% [34]). Evans then
suggested that raw cow’s milk might be involved in the trans-
mission of undulant fever to humans. In 1922, even though
she had used precautions in her research, Evans became
infected, and the microorganism was isolated from her blood.
(The respiratory tract might have been the route of infec-
tion.). She subsequently suffered years of poor health or dis-
ability alternating with periods in which she felt that she
recovered. At the meeting of The Society of American
Bacteriologists (currently American Society for Micro-
biology, ASM) held in December 1927, she was elected
President but could not attend the meeting because she was
bedridden due to a relapse of her brucellosis. When  Evans
suffered the last disabling episode of the disease in 1943 she
had already developed hypersensitivity to brucellar antigens
and was no longer able to work with live cultures.
Nonetheless, her own experience as a patient lead to valuable
insights in her study of chronic brucellosis [9,32,35,48].
Bartonella, the missing link. La Oroya is a Peruvian
mining town located 180 km east of Lima in a deep, narrow
valley 3371 meters above the sea level, where the rivers
Mantaro and Yauli met. With a population of around 35,000,
the town is notorious for being ranked among the ten most
polluted locations in the world [8] due to emissions from a
smelter facility. During the second half of the nineteenth cen-
tury La Oroya was also notorious because of another health
problem. In 1870, an epidemic of fever and anemia with a
mortality of almost 100% killed thousands of the workers
who were building the railway from Lima to the mining cen-
ters in the central Andes [6]. Because the disease was restrict-
ed to La Oroya and its valley, medical authorities called it
“Oroya fever” until the eponym “Carrión’s disease” became
in use to honor Daniel Alcides Carrión (1857-1885), the
medical student who proved that Oroya fever was another
clinical manifestation of the disease known as “Peruvian
wart,” endemic in the region, but benign. The price he paid to
prove the connection was, however, very high: his own life.
Carrión was a student at the School of Medicine of San
Marcos University, the only medical school at that time in
Peru, and like his classmates and instructors, felt attracted to
the study of diseases unique to a region of his country. In
August 1885, he asked a classmate to inoculate him with
blood drawn directly from the warts of a young female
patient. Three weeks later, instead of warts on his skin,
Carrión developed the first symptoms of Oroya fever. He was
aware of his condition and understood that the two endemic
diseases were actually the same. He made notes on the
progress of his disease until he felt so ill that he was no
DANGEROUS MICROBIOLOGY
220 INT. MICROBIOL. Vol. 10, 2007
longer able to write. Then he asked his classmates to contin-
ue his medical diary on his behalf. He died on October 5,
1885; the date now marks the annual celebration of
“Peruvian Medicine Day” [6].
In 1909, the Peruvian physician Alberto E. Barton (1870-
1950) published an article in La Crónica Médica describing
what he considered to be infectious particles in red blood
cells of Carrion’s disease patients, and called them “X parti-
cles” or “endoglobular elements.” They were shaped like
bacilli and differed from any other known microorganism.
He noted that in Oroya fever the bacilli proliferated, whereas
they almost disappeared when the patients developed warts
[6]. Other researchers, including physicians Richard P.
Strong and Hideyo Noguchi, and entomologist Charles
Towsend, who worked in the USA and participated in expe-
ditions to Peru, contributed to a better understanding of the
causal agent of Carrión’s disease [6], which nowadays is
“viewed as a medical curiosity” [2]. Strong confirmed that
the endoglobular bodies Barton described were bacilli and
proposed a new genus and species, which he named
Bartonella bacilliformis in honor of Barton. Noguchi trav-
eled to Peru in 1919 as a member of the Rockefeller
Foundation commission that was studying yellow fever (see
the section on yellow fever below) and became familiar with
Oroya fever and Peruvian wart, which he studied along with
Telémaco Battistini, a Peruvian student at the Rockefeller
Institute in New York. During the 1920s they published a
series of articles describing their experiments, which con-
firmed that the diseases were indeed two distinct clinical
manifestations of the same infection. (The final report was
signed by Noguchi alone in 1927.) Towsend identified a noc-
turnal sandfly, known in Peru as the titira (Phlebotomus ver-
rucarum, now Lutzomya verrucarum), as the vector of Oroya
fever.
The history of bartonellosis records two other cases of
researchers who became self-infected: Ovidio García Rosell
and Maxime Kuczynski-Godard (1890-1967). García
Rosell, whose medical specialty was phthisiology, fell ill
with symptoms that were first attributed to tuberculosis,
which he was assumed to have contracted from a patient.
However, his fever soon disappeared and some time later he
broke out in Peruvian warts. Before falling ill, he had
pricked himself accidentally with a needle contaminated
with the blood of a patient with the severe anemia of
Carrión’s disease, and this must have been the cause of the
infection. In contrast,  Kuczynski-Godard, a German-
Peruvian physician, intentionally inoculated himself with
infected blood 11 times over 37 days. Fortunately, the out-
come was only the development of warts, as he later
described in an article published in 1937 [5].
The power of faith. In 2003, Hospital Doctor, a British
weekly magazine aimed at the hospital sector, organized a
poll to identify the “greatest doctor ever.” John Snow (1813-
1858), who carried out seminal epidemiologic research to
trace the source of a cholera outbreak in London in 1854,
won the poll [Dr John Snow named the greatest doctor. John
Snow site. UCLA http://www.ph.ucla.edu/epi/snow/ snow-
greatestdoc.html]. John Snow’s study, along with two other
contemporary studies of the same cholera epidemic—a study
of a localized outbreak in Broad Street, and an official study
of the whole epidemic—took place a quarter-century before
Robert Koch’s description of Vibrio cholera as the causal
agent of this fearsome disease. 
Two of the scientists who participated in these studies
described the presence of vibriones (in conventional nine-
teenth-century medical terminology, ‘vibriones’ were motile,
elongated microscopic organisms) in several samples they
analyzed. Richard Dundas Thomson (1810-1864), professor
of chemistry at St. Thomas Hospital, observed them in dis-
tilled water in which air from a ward full of cholera patients
had been trapped. Arthur Hill Hassall (1817-1894), author of
the first English textbook on microscopic anatomy of the
human body, also saw vibriones in rice-water stools of
cholera patients. These findings well fit with the hypothesis
of Snow, who believed that the origin of cholera was most
probably a live organism which could be ingested accidental-
ly from sources contaminated with feces, and then multiply
in the body to be expelled in the rice-water stools, which
were the cause of transmission. He even calculated an incu-
bation period of 24–48 hours before the onset of the disease.
However, the prevailing paradigm was that the origin of epi-
demic diseases lay in the influence of decaying organic mat-
ter, and that the “miasmas” that emanated from such matter
caused the disease when inhaled. Hence, the presence of vib-
riones was considered an epiphenomenon of the disease, not
an explanation of its origin [33].
Thomson and Hassall were not the only ones to have
noticed that vibriones were related to cholera before Robert
Koch (1843-1910) did. Italian physician Filippo Pacini
(1812-1883) became interested in the disease when the
Asiatic cholera pandemic of 1846–1863 reached Florence,
his hometown. He described the vibriones, found in myriads
when he observed tissues of dead cholera patients, in his arti-
cle Osservazioni microscopiche e deduzioni patologiche sul
cholera asiatico, published in 1854. Only in 1965 was
Pacini’s discovery recognized, when the Judicial Com-
mission of the International Committee on Bacteriological
Nomenclature added his name to that of the species, so that
now the correct name of the species is Vibrio cholerae Pacini
1854 [17].
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In 1883, cholera threatened to spread throughout Europe.
By then Robert Koch had already found the causal agents of
anthrax and tuberculosis, and the Koch-Henle postulates for
the definition of microbial pathogens had been established.
Germany and France sent their best bacteriologists to Egypt
to study the disease [21]. Koch traveled there with George
Gaffky (1850-1917) and Bernard Fischer (1852-1915),
whereas the French team included Isidore Strauss, Emile
Roux (1853-1933), Edmond Nocard (1850-1903), and Louis
Thuillier (1856-1883). In Alexandria, where the European
research teams established their headquarters, misfortune
accompanied the French expedition. On September 17, 1883
the young bacteriologist Thuillier became infected with
cholera, and neither of his physicians colleagues could save
his life. Thuillier died on September 19, a victim of the dis-
ease he had studied [17,21]. When the Egyptian epidemic
faded, the German team traveled to India to continue work in
Calcutta, which seemed to be a promising location for their
research. It was in Calcutta that Koch finally succeeded in
isolating the cholera bacterium in pure culture.
When Koch’s team returned to Germany, they stopped in
Munich, on their way to Berlin, to pay a visit to the Bavarian
medical chemist Max von Pettenkofer (1810-1901), a noted
experimental hygienist and strong believer in the miasma
theory. He was convinced that the microbe played only a sec-
ondary role, and claimed that there must be a specific factor
in soils for the germ to develop and produce the infectious
material that eventually would cause cholera. The disease,
according to von Pettenkofer, could not be transmitted per-
son-to-person; instead, transmission must depend mainly on
the condition of the soils. Koch presented to von Pettenkofer
the results of his research in Egypt and India, but did not suc-
ceed in convincing him. Even though von Pettenkofer was
wrong, the efforts he made to improve hygiene and sanitation
in Munich reduced the incidence of cholera in that city,
which reinforced his belief in the miasma theory. In 1892 he
wrote to Koch to ask him for a sample of cholera germs.
When von Pettenkofer received the sample, he diluted it in a
flask of a meat gravy and swallowed the whole contents of
the flask. The dose might have killed him, but he was fortu-
nate enough to suffer only diarrhea over the following sever-
al days. Once he had recovered, he sent a note to Koch to
thank him for the sample. In the note he also wrote that “Herr
Doctor von Pettenkofer has now drunk the entire contents
and is happy to be able to inform Herr Doctor Professor
Koch that he remains in his usual good health” [17,46]. Von
Pettenkofer’s conclusion from not having developed symp-
toms of cholera was that Vibrio cholera did not cause the dis-
ease. What he actually proved was that exposure to the bac-
terium was not enough for a person to develop the disease.
Rickettsial diseases. At the turn of the twentieth cen-
tury a mysterious deadly disease of unknown origin afflicted
the settlers of the Bitterroot Valley in western Montana,
USA, in spring and summer. The main symptoms were high
fever, chills, muscle aches and headache. A rash that looked
like small red spots or blotches and usually appeared on the
third to fifth days after the first symptoms gave the disease its
name: Rocky Mountain spotted fever. The Montana State
Board of Health, set up in 1901, placed high priority on
investigating the cause of the disease. During the first
decades of the twentieth century, researchers from other
regions of the country came to Montana hoping to find the
cause of the disease and to develop an effective treatment.
Among these researchers was Howard Taylor Ricketts (1871-
1910), a pathologist and excellent microscopist from the
University of Chicago. In 1906, Ricketts showed that the
agent of spotted fever was present in the blood of infected
humans and that it could be removed by filtration. Other
researchers, including Louis B. Wilson and William M.
Chowning from the University of Minnesota, suggested that
the wood ticks were the vector of spotted fever, based on the
facts that the disease was seasonal and that in all cases there
was a history of exposure to a tick of the genus Dermacentor
[41]. Ticks, like mosquitoes, were then thought to carry only
protozoan parasites. In 1904, Wilson and Chowning assumed
that the causal agent was a protozoan, and they even report-
ed the presence of Pyroplasma (currently Babesia) in the
blood of patients suffering from spotted fever.
In 1909, Ricketts reported that freshly laid eggs of infected
Dermacentor ticks were “laden with astonishing numbers of
an organism which appears typically as a bipolar staining
bacillus of minute size,” which seemed to confirm Wilson and
Chowning’s claim [38]. In contrast to the attitude of other
researchers, however, Ricketts was prudent in his claims
regarding the role of the microorganism he had found , and
wrote that “[i]n spite of the constancy with which these bodies
were found, it did not seem justifiable to claim that they repre-
sent the microparasite of the disease.” He did not even name
the microorganism but suggested only that it might “be
referred to tentatively as the bacillus of Rocky Mountain spot-
ted fever” [38].
A state budget shortage in Montana in 1910 made the
continuity of Ricketts’ funded research in Bitterroot Valley
uncertain, so he accepted an offer to go to Mexico to study
epidemic typhus [History of Rocky Mountain Labs,
http:www3.niaid.nih.gov/about/organization/dir/rml/histo-
ry/htm]. He had been invited to move to the Rockefeller
Institute in New York, but he declined because he did not
want to give up the subject of diseases transmitted by mos-
quitoes, fleas, and other arthropods. In addition, he was eager
DANGEROUS MICROBIOLOGY
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to work in Mexico, especially when he learned that two
researchers employed by the Mexican Government had been
able to transfer epidemic typhus fever to monkeys by inocu-
lating them with blood from a patient diagnosed with the dis-
ease. In Mexico, Ricketts fell ill on April 18, 1910, when he
was about to return home. He made notes describing the
development of his disease, and although he thought he was
recovering, he eventually died from heart failure. He had
already described the pathogen that killed him: a tiny bacil-
lus he had found in the lice and the blood from patients suf-
fering the disease, which very much resembled the one caus-
ing Rocky Mountain spotted fever. In 1916, Brazilian bacte-
riologist Henrique de Rocha Lima (1879-1956) named the
typhus causal agent Rickettsia prowazekii in honor of
Ricketts and parasitologist Stanislaus von Prowazek (1875-
1915), another researcher who died from epidemic typhus.
Von Prowazeck, who had studied the disease in the Balkans
in 1913, was asked to study it in a Russian prisoner-of-war
camp near Cottbus, southeast from Berlin. There he became
infected and died [18,25,36].
Thomas Bailey McClintic, who also worked for the
Montana State Board of Health supervising the measures for
the eradication of Rocky Mountain spotted fever, was anoth-
er victim of the disease he studied. An infected tick bit
McClintic as he was working in the laboratory in 1912. He
died on his way back to Washington to be with his wife and
children [American Journal of Public Health, 2(9), September
1912, Editorial, p. 713]. Also in Montana, Henry Cowan, a
field worker who gathered ticks for researchers from 1918 to
1924, and William Gittinger, a young researcher with whom
Cowan worked, were victims of spotted fever. Cowen died in
1924 just as a vaccine for the disease was being tested. For
him, the vaccine arrived too late [Devlin S. Spotted fever
researchers. In: The 100 most influential Montanans of the
Century. Missoulian Online http://www.missoulian.com
/specials/100montanans/list/051.html]
The pioneers of yellow fever research. Among
researchers who worked on the discovery of the cause of yel-
low fever, several were victims of the infectious disease they
had tried to fight. Among the best known is the case of
Japanese-American bacteriologist Hideyo Noguchi (1876-
1928), who worked at the Rockefeller Institute. Noguchi, dis-
regarding previous work by other researchers who had report-
ed that yellow fever was caused by a filterable virus, claimed
that the causal agent was a spirochete. He even described the
isolation and characteristics of the bacterium, which he called
“Leptospira icteroides” [30,31]. Repeated attempts by other
researchers to prove that L. icteroides was also the cause of the
disease in Western Africa had failed, and Noguchi was deter-
mined to prove that the bacterium was the only cause of the
disease [28]. Noguchi died from yellow fever on May 28, 1928
in Accra, Ghana, where he had traveled to study the disease.
His death preceded by two days that of William A. Young,
director of the British Institute for Medical Research in Accra.
Other researchers from the Institute suspected that Young
might have inoculated himself with blood from Noguchi dur-
ing the initial days of Noguchi’s disease.
On September 19, 1927, several months before the deaths
of Noguchi and Young, the Irish physician Adrian Stokes
(1887-1927) died from laboratory-acquired yellow fever in
Lagos, Nigeria. Stokes was on a sabbatical with the West
African Yellow Fever Commission, which was funded by the
Rockefeller Foundation. Along with two American col-
leagues (Johannes H.Bauer and N. Paul Hudson), he worked
with an animal model, the rhesus macaque (currently
Macaca mulatta), to which they applied Koch’s postulates to
prove that yellow fever was caused by a virus and not by
Noguchi’s leptospira spirochete. The experiment succeeded
and was to become a milestone in virology. However, when
the work was close to completion, Stokes contracted the dis-
ease in the laboratory and died [40].
Other researchers had died earlier from yellow fever. In
1798, Elihu H. Smith (1771-1798), a physician from
Connecticut, succumbed to the disease, which he had
described in several articles published in Medical Repository,
a journal he had co-founded with Samuel L. Mitchill and
Edward Miller. (Medical Repository was published from
1797 to 1824, and is considered the first medical journal pub-
lished in the USA) [20]. In 1900, Jesse William Lazear
(1866-1900), member of the US Army Yellow Fever Board—
the other members were Walter Reed (1851-1902), James
Carroll (1854-1907) and Arístides Agramonte (1868-1931)—
died in Cuba after having been bitten by a mosquito infected
with the disease that the Board was studying.
Officially, Lazear was infected “incidentally.” Some of
his notes, however, suggested that he intended to prove that
the mosquito was actually the vector of the disease. [Bauer &
Hudson; Philip S. Hench Walter Reed Yellow Fever
Collection: yellowfever.lib.virginia.edu/reed/lazear.html]. In
a letter that Agramonte wrote to the Cuban microbiologist
Carlos J. Finlay (1833-1915) on April 12 1905, he recalled
the cases of Lazear and James Carroll, the two members of
the Board who had become infected during the experiments
in which he himself also participated. According to
Agramonte, Carroll did not believe that mosquitoes were the
vectors of yellow fever and he did not do anything to prevent
them from biting him. He contracted the disease but was for-
tunate enough to survive.The case of Lazear was different.
He had been in Europe in 1894 and 1895; in addition to stay-
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ing for some time at the laboratories of Robert Koch (1843-
1910), Emil Roux (1855-1933) and Elie Metchnikoff (1845-
1916), he also worked at the laboratory of Giovanni Battista
Grassi (1854-1925) in Rome, where he became acquainted
with Grassi’s discoveries on the role of a mosquito species in
the transmission of malaria [3,23]. Lazear became convinced
that a mosquito was also the vector of yellow fever. On
September 13, 1900 he allowed one of the infected mosqui-
toes caught by the staff of the Board at Las Animas Hospital
to bite him. Five days later he fell ill and realized he had yel-
low fever. He soon developed albuminuria and jaundice and
eventually died on September 25, 1900 “a victim of scientif-
ic zeal and indeed as a hero” [Letter by Agramonte to Finlay,
reproduced in Cuadernos de Historia de la Salud Pública
(Cuba) 2002, 92:87-88].
Eastern equine encephalitis. Equine encephalitis is
a zoonosis that was first reported in Massachusetts in 1831,
when 75 horses died from an unknown type of
encephalomyelitis. Until the 1930s it was a veterinary dis-
ease never recorded in humans. In 1931, Swiss-born veteri-
narian Karl Friedrich Meyer (1884-1974) and his colleagues
at the George Williams Hooper Foundation for Medical
Research-University of California described the virus caus-
ing equine encephalomyelitis and reported that they had
noted three people with symptoms that might be due to the
virus. Meyer suggested the possibility that humans could also
contract the equine disease. In a memorable lecture, he called
attention to the major role that the animal kingdom could
play as a reservoir of human pathogens. [39].
In 1933, Carl Ten Broeck (1885-1966) and Malcom H.
Merrill (1903-1987) isolated the virus during an epizootic on
the North American Atlantic coast [15]. In 1938, coinciding
with an outbreak of encephalomyelitis in horses in
Massachusetts, eight cases of human encephalitis occurred in
the same area as the equine disease. The analysis of brain tis-
sue from patients who died revealed the presence of the east-
ern strain of the equine encephalomyelitis virus. These were
the first cases of human equine virus for which there was
microbiological evidence [10]. Since then, cases have
occurred sporadically as well as in small epidemics, mostly
along the eastern and Gulf coasts of the USA (hence the
adjective “eastern” in the name of the disease). From 1955 to
1993 there were 223 cases reported to the US Center for
Disease Control and Prevention (CDC) with a peak of 36 cases
in 1959, when there was an outbreak in New Jersey [7,14].
Richard E. Shope (1901-1966) was a brilliant virologist at
the Rockefeller Institute for Medical Research in New York
who studied the eastern equine encephalitis virus and became
infected with it in 1959. Shope had worked in Ocean County,
New Jersey, where there had been 18 cases with 10 deaths
[New Jersey Mosquito Control Agency, at http://www.rci.rut-
gers.edu/~insects/oceprof.htm], and had collected mosqui-
toes suspected of carrying the virus. He was bitten and, when
he started to have chills with muscle and joint pain, he asked
a colleague, Delphine Clarke, to take a sample of his blood
and examine it to search for the encephalitis virus, which she
found. Up to then the virus had usually been isolated from
brain and other tissues after the patient’s death; so that was
the first time the virus had been found in the blood of a
patient. The virus did not attack Shope’s brain; in fact, he sur-
vived and escaped paralysis and other frequent consequences
of the disease such as mental impairment.
Out of Africa. Among the emerging diseases of the twen-
tieth century, Lassa fever virus has become a growing public
health concern, not only in the African countries where major
outbreaks take place, but also in developed countries that
have recorded patients with imported Lassa fever. Along with
Hantavirus fevers, Lassa fever affects more people that any
other hemorrhagic fever. Lassa fever owes its name to the
Nigerian village of Lassa, where the first cases were detect-
ed in the 1950s [12]. The virus was not isolated, however,
until 1969. Sonia Buckley (1918-2005), Jordi Casals-Ariet
(1911-2004) and Wilbur G. Downs (1913-1991), from The
Yale Arbovirus Research Unit at Yale University, isolated it
from three missionary nurses from the USA who worked in
northern Nigeria and became ill. Two of the nurses died, and
the third one was sent to the USA, where she recovered after
a nine-week stay in Columbia-Presbyterian Hospital in
Manhattan, NY. In June 1969, Casals-Ariet fell ill, but did
not initially relate his severe thigh-muscle pain to the disease
because the nurses had not manifested this symptom. The
physicians who were treating him were soon convinced that
he had Lassa fever, but confirming the diagnosis would have
taken 96 hours, and Casals-Ariet, who was already severely
ill, would surely not have survived. His doctors took a risky
decision: they called the nurse who had survived the first out-
break of the disease, took some of her blood, separated the
plasma fraction that contained antibodies, and injected them
into Casals-Ariet, who then recovered. Had he not been
infected with the Lassa virus, however, the injection of the
antibodies could have caused a dangerous cross-reaction [22;
Altman LK (2004) Jordi Casals-Ariet, who found the Lassa
virus, dies at 92. The New York Times, February 21, 2004].
Around Thanksgiving that same year, Juan Roman, a techni-
cian working on Casals-Ariet’s team, fell ill and died a few
weeks later. When it was confirmed that he had died from
Lassa fever the team stopped working with live virus, and the
remaining samples they had were sent to the CDC, where
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they were kept in a biosafety laboratory. How Casals-Ariet
and Roman became infected has never been discovered,
which is disturbing because Roman, as a technician, had
never worked directly with the virus. Some of their col-
leagues suggested that they might have inhaled viruses from
dust in the cages of infected mice at Casals-Ariet’s laborato-
ry [Powell K (2004) A life among viruses. originally pub-
lished in Yale Medicine, Fall/Winter 2004. Available online
at http://yalemedicine.yale.edu/ym_fw04/capsule.html].
Event though Lassa fever is a rodent-borne disease, per-
son-to-person transmission is also possible, and major out-
breaks have occurred in homes and hospitals in Western
Africa, associated with inadequate sanitary conditions and
direct contact with infected blood and contaminated needles
and syringes [12]. Of the 24 cases reported worldwide of
patients with Lassa fever imported from Western Africa from
1969 to 2004, four occurred in physicians, four in nurses, and
three in aid workers [24], who are often in contact with the
poorest people or work in hospitals. In a study published in
1995 on cases of nosocomial Lassa fever in two hospitals in
Nigeria [11], the authors concluded that the nosocomial out-
breaks they had studied were the result of introducing mod-
ern medicine, mainly parenteral drugs and surgery, in inade-
quately equipped hospitals (where scarce disposable equip-
ment was often shared or reused), whose staff had received
little formal education or professional training acquired on
the job. In fact, no outbreaks have been reported in the com-
munity or in better-managed hospitals in Nigeria.
Checking Koch’s postulates. The incidents at The
Yale Arbovirus Research Unit during research on Lassa fever
led to changes in biosafety practices. In the USA, and also in
other countries, strong measures to prevent infections when
handling highly hazardous microbials have been adopted.
Nowadays no one expects any microbiologist to infect him-
self or herself to prove or disprove a hypothesis. However, in
1982, Barry Marshall, codiscoverer, with J. Robin Warren, of
the role of Helicobacter pylori as causal agent of gastric
ulcers—for which they were awarded the 2005 Nobel Prize of
Physiology or Medicine—swallowed a culture of the bacteri-
um to prove his and Warren’s hypothesis, which had been
greeted with skepticism by their colleagues.
In the twentieth century, with the development of psycho-
somatic medicine, which linked the psyche and the body,
many physical disorders of unknown etiology were consid-
ered to be biological manifestations of psychological distur-
bances. In the 1940s, peptic ulcer was considered a chronic
psychosomatic disease attributed to stress and lifestyle [27].
Around 1970 the application of fiber optics to endoscopy
made it possible to easily examine the stomach. The diagno-
sis of gastric and duodenal ulcers became easier, and gas-
troenterologists could take small biopsies from the lining of
the stomach and study the pathophysiology of ulcer disease.
Soon it became obvious that most people suffering from
ulcer had also gastritis. The discovery of H2 receptors in the
1970s was a great advance in the treatment of peptic ulcers.
Tagamet®, the first H2-receptor antagonist, was released for
sale around 1975. It was a sort of magic drug capable of heal-
ing ulcers. No longer was it necessary for patients to take
massive doses of antacids, nor did they need to be hospital-
ized except in extreme cases. However, Tagamet and other
H2-receptor antagonists that were produced later were effec-
tive only if administered regularly. This characteristic, and
the fact that peptic ulcer was a widespread disease in human
populations made Tagamet the most profitable drug in the
history of pharmacology between 1975 and 1980.
In 1979, Robin Warren, from Royal Perth Hospital, in
Perth, Western Australia, reported finding spiral bacteria in
samples from gastric biopsies of patients who had endo-
scopies. Warren found no previous reports in medical texts of
these bacteria, which were apparently associated to gastritis,
and his discovery was overlooked by his colleagues, proba-
bly because gastritis was not recognized as a major disease.
In July 1981 Marshall joined Robin Warren’s team, as post-
doc. Although other researchers had found spiral bacteria in
the stomach, Warren and Marshall were the first to suggest
that they might be the causal agent of peptic ulcers. Marshall
was asked to study the clinical records of patients suffering
from gastritis and try to find any potential correlation
between the presence of the bacteria and food, oral medica-
tion, or lifestyle, but he found no such associations.
Apparently, anybody could become infected, but only people
with the bacteria in their stomach developed ulcers. He and
Warren succeeded at growing the bacterium, which turned
out to be a new species similar to members of the genus
Campylobacter, and that was not exclusive to Australia. In
fact, Marshall studied histological preparations of gastric
mucosasamples from the USA and the Netherlands, and the
Campylobacter-like (now Helicobacter pylori) bacteria were
also there.
To prove that these Campylobacter-like bacteria were the
causal agents of gastritis and ulcers, it was necessary to inoc-
ulate an animal with the bacterium and show that it became
infected. Marshall carried out these experiments but did not
succeed in proving his and Warren’s hypothesis. So he decid-
ed to infect himself with the bacterium, and swallowed the
contents of a culture of the Campylobacter-like bacteria.
After a week he felt the first symptoms of acute gastritis, con-
firmed by a biopsy that revealed the presence of the bacteri-
um. Koch’s postulates had been proved. Fortunately, gastric
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ulcer is not a lethal disease. In addition, the treatment that
they envisaged for the disease—a combination of bismuth
with antibiotics—was successful, and Marshall soon recov-
ered. Warren could not experiment on himself because he
was already suffering from gastric ulcer! [Rose J (2000)
Marshall J. Robin Warren - Interview, available at
http://nobelprize.org; Marshall BJ (1998) Peptic ulcers,
stomach cancer and the bacteria which are responsible (lec-
ture given by Marshall as the recipient of the 1998 Heineken
Prize for Medicine, available at http://www.knaw.nl/
heinekenprizes/pdf/37.pdf]. 
The Vietnam hero. Severe acute respiratory syndrome
(SARS) is an emerging disease of the twenty-first century
caused by an unusual influenza-like virus. The first outbreak
occurred in the Vietnam-French Hospital in Hanoi, Vietnam
in 2003, and more than half of the 60 patients affected by the
disease belonged to the hospital staff. Aware of the potential
danger of the infection, many of them decided to quarantine
themselves inside the hospital, to protect their families and
the community. Carlo Urbani (1956-2003), from the World
Health Organization (WHO) office in Hanoi, had been called
in as an epidemiological and clinical expert to examine the
patients at the Vietnam-French Hospital. He recognized the
severity of the disease and the need to establish infection
control safeguards, and warned the WHO, which made it
possible to promptly develop coordinated global actions to
keep the new disease under control [4].
Urbani was a member of the SARS working group that
identified a novel coronavirus associated with the outbreak,
and participated in the preparation of the manuscript describ-
ing the virus. Unfortunately, he could not see the printed arti-
cle that reported the group’s discovery, which was published
in the March 31, 2003 issue of the New England Journal of
Medicine: he died in Bangkok two days before the release of
the issue. Urbani’s wife was very concerned about his hus-
band’s close contact with patients suffering from such a
severe and highly contagious disease. Urbani told her “If I
cannot carry out my work as a physician under these circum-
stances, why I am here? To answer e-mails, attend cocktail
parties representing the WHO, and write mission reports?”
[1]. On March 11, during a flight to Bangkok, where he was
to attend a meeting, Urbani felt the first symptoms of the dis-
ease, and on his arrival he told a colleague from the CDC no
to approach him too closely and to call an ambulance. [37,4].
He was hospitalized and died on March 29. The abundant
correspondence and reports he sent to colleagues, mainly at
the WHO and the CDC from March 4 to March 10—his last
week at work before falling ill—illustrates his uncommon
abilities as a clinician, his competence as an epidemiologist
and expert in infectious diseases, and his devotion to patients.
The report he wrote on March 10 was the first report to be
released internationally [1].
Concluding remarks. Nowadays, laboratories where
infectious microorganisms are studied have adopted strict
biosafety standards regarding practices, equipment and facil-
ities to prevent any possible hazard to the staff, the environ-
ment and the community. In the last few years, some coun-
tries including the USA seem to be more concerned over
biosecurity than over biosafety, and have adopted measures
to prevent access to microorganisms that could be used as
bioweapons. After several cases in which scientists have
been charged with infringing the rules for the handling of
hazardous biological materials, others have given up their
research and considered that dangers coming from political
interference can be even worse than those intrinsic to their
own work in the laboratory.
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